|
US7230098B2
(en)
*
|
2003-02-26 |
2007-06-12 |
Sugen, Inc. |
Aminoheteroaryl compounds as protein kinase inhibitors
|
|
JP2007523188A
(ja)
*
|
2004-02-23 |
2007-08-16 |
スゲン，インコーポレイティド |
Ｃ−ｍｅｔ阻害薬及びｍ−ｔｏｒ阻害薬を使用する異常な細胞増殖の治療法
|
|
AU2005217328B2
(en)
*
|
2004-02-27 |
2007-10-04 |
Eisai R & D Management Co., Ltd. |
Novel pyridine derivative and pyrimidine derivative (2)
|
|
WO2005095386A1
(en)
*
|
2004-03-30 |
2005-10-13 |
Chiron Corporation |
Substituted thiophene derivatives as anti-cancer agents
|
|
US8008301B2
(en)
|
2004-04-01 |
2011-08-30 |
Eli Lilly And Company |
Histamine H3 receptor agents, preparation and therapeutic uses
|
|
CN1960969B
(zh)
|
2004-04-01 |
2012-03-28 |
伊莱利利公司 |
组胺h3受体药物、其制备方法及治疗用途
|
|
JP4942654B2
(ja)
*
|
2004-08-23 |
2012-05-30 |
イーライ リリー アンド カンパニー |
ヒスタミンｈ３受容体薬剤、製剤及び治療的使用
|
|
JP2008510792A
(ja)
*
|
2004-08-26 |
2008-04-10 |
ファイザー・インク |
タンパク質チロシンキナーゼ阻害剤としてのアミノヘテロアリール化合物
|
|
AP2373A
(en)
|
2004-08-26 |
2012-03-07 |
Pfizer |
Enantiomerically pure aminoheteroaryl compounds asprotein kinase inhibitors.
|
|
RU2007106863A
(ru)
*
|
2004-08-26 |
2008-08-27 |
Пфайзер Инк. (US) |
Энантиоселективное биопреобразование для получения промежуточных соединений ингибитора белка тирозинкиназы
|
|
NZ552946A
(en)
*
|
2004-08-26 |
2010-09-30 |
Pfizer |
Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
|
|
GT200600042A
(es)
*
|
2005-02-10 |
2006-09-27 |
Aventis Pharma Inc |
Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
|
|
AU2006218404A1
(en)
*
|
2005-03-03 |
2006-09-08 |
Sirtris Pharmaceuticals, Inc. |
N-phenyl benzamide derivatives as sirtuin modulators
|
|
MX2007013986A
(es)
*
|
2005-05-13 |
2008-02-22 |
Lexicon Pharmaceuticals Inc |
Compuestos multiciclicos y metodos para su uso.
|
|
US7855289B2
(en)
*
|
2005-08-04 |
2010-12-21 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
US8093401B2
(en)
*
|
2005-08-04 |
2012-01-10 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
US8088928B2
(en)
*
|
2005-08-04 |
2012-01-03 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
ES2431050T3
(es)
*
|
2005-08-04 |
2013-11-22 |
Sirtris Pharmaceuticals, Inc. |
Benzotiazoles y tiazolopiridinas como moduladores de la sirtuína
|
|
JP4077028B2
(ja)
|
2005-08-24 |
2008-04-16 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
新規ピリジン誘導体およびピリミジン誘導体（３）
|
|
BRPI0619424B1
(pt)
*
|
2005-12-05 |
2022-02-08 |
Pfizer Products Inc |
Uso de inibidores c-met/hgfrs para a fabricação de medicamentos
|
|
US8217057B2
(en)
*
|
2005-12-05 |
2012-07-10 |
Pfizer Inc. |
Polymorphs of a c-MET/HGFR inhibitor
|
|
PE20070978A1
(es)
*
|
2006-02-14 |
2007-11-15 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
|
|
JP2009529047A
(ja)
|
2006-03-07 |
2009-08-13 |
アレイ バイオファーマ、インコーポレイテッド |
ヘテロ二環系ピラゾール化合物およびその使用
|
|
JP2009533327A
(ja)
*
|
2006-03-22 |
2009-09-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
増殖性疾患を処置するためのｃ−ＭＥＴキナーゼ阻害剤
|
|
US7700339B2
(en)
|
2006-04-14 |
2010-04-20 |
Cell Signaling Technology, Inc. |
Gene defects and mutant ALK kinase in human solid tumors
|
|
US8168383B2
(en)
|
2006-04-14 |
2012-05-01 |
Cell Signaling Technology, Inc. |
Gene defects and mutant ALK kinase in human solid tumors
|
|
US7601716B2
(en)
|
2006-05-01 |
2009-10-13 |
Cephalon, Inc. |
Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
|
EP2338488A1
(en)
*
|
2006-05-26 |
2011-06-29 |
Bayer HealthCare, LLC |
Drug combinations with substituted diaryl ureas for the treatment of cancer
|
|
US20110053931A1
(en)
*
|
2006-06-08 |
2011-03-03 |
John Gaudino |
Quinoline compounds and methods of use
|
|
CA2660836A1
(en)
|
2006-08-07 |
2008-02-21 |
Incyte Corporation |
Triazolotriazines as kinase inhibitors
|
|
CA2661333C
(en)
|
2006-08-23 |
2014-08-05 |
Eisai R&D Management Co., Ltd. |
Salt of phenoxypyridine derivative or crystal thereof and process for producing the same
|
|
US7790885B2
(en)
*
|
2006-08-31 |
2010-09-07 |
Eisai R&D Management Co., Ltd. |
Process for preparing phenoxypyridine derivatives
|
|
WO2008042867A2
(en)
*
|
2006-09-29 |
2008-04-10 |
Emiliem Inc. |
Modulators of multiple kinases
|
|
AU2007309427B2
(en)
|
2006-10-23 |
2013-02-28 |
Cephalon, Inc. |
Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors
|
|
GB0621607D0
(en)
*
|
2006-10-31 |
2006-12-06 |
Chroma Therapeutics Ltd |
Inhibitors of c-Met
|
|
MX2009005144A
(es)
|
2006-11-22 |
2009-05-27 |
Incyte Corp |
Imidazotriazinas e imidazopirimidinas como inhibidores de cinasa.
|
|
CN101558040B
(zh)
|
2006-12-14 |
2013-03-27 |
拜耳先灵医药股份有限公司 |
用作蛋白激酶抑制剂的二氢吡啶衍生物
|
|
JP2010516680A
(ja)
*
|
2007-01-19 |
2010-05-20 |
エックスカバリー，インコーポレイテッド |
キナーゼ阻害薬化合物
|
|
WO2008087736A1
(ja)
*
|
2007-01-19 |
2008-07-24 |
Ube Industries, Ltd. |
アラルキルオキシ又はヘテロアラルキルオキシ基を有する芳香族アミンの製法
|
|
US8715665B2
(en)
|
2007-04-13 |
2014-05-06 |
The General Hospital Corporation |
Methods for treating cancer resistant to ErbB therapeutics
|
|
DK2134685T3
(en)
*
|
2007-04-16 |
2015-12-07 |
Abbvie Inc |
7-unsubstituted indole derivatives as MCL-1 inhibitors
|
|
US8263585B2
(en)
|
2007-05-04 |
2012-09-11 |
Novartis Ag |
Organic compounds
|
|
CL2008001822A1
(es)
*
|
2007-06-20 |
2009-03-13 |
Sirtris Pharmaceuticals Inc |
Compuestos derivados de tiazolo[5,4-b]piridina; composicion farmaceutica que comprende a dichos compuestos; y uso del compuesto en el tratamiento de la resistencia a la insulina, sindrome metabolico, diabetes, entre otras.
|
|
SG183036A1
(en)
|
2007-07-17 |
2012-08-30 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
MX2010001020A
(es)
*
|
2007-07-26 |
2010-03-01 |
Novartis Ag |
Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas.
|
|
US8748143B2
(en)
|
2007-09-13 |
2014-06-10 |
Codexis, Inc. |
Ketoreductase polypeptides for the reduction of acetophenones
|
|
BRPI0820410A2
(pt)
*
|
2007-10-23 |
2015-05-19 |
Allergan Inc |
Lactans substituídos terapêuticos
|
|
WO2009058348A1
(en)
*
|
2007-11-01 |
2009-05-07 |
Sirtris Pharmaceuticals, Inc. |
Amide derivatives as sirtuin modulators
|
|
WO2009061453A1
(en)
*
|
2007-11-08 |
2009-05-14 |
Sirtris Pharmaceuticals, Inc. |
Solubilized thiazolopyridines
|
|
JP2009132660A
(ja)
*
|
2007-11-30 |
2009-06-18 |
Eisai R & D Management Co Ltd |
食道癌治療用組成物
|
|
WO2009073224A1
(en)
*
|
2007-12-07 |
2009-06-11 |
Ambit Biosciences Corp. |
Methods of treating certain diseases using pyrimidine derivatives
|
|
US20090227556A1
(en)
*
|
2008-01-31 |
2009-09-10 |
Eisai R&D Management Co., Ltd. |
Receptor tyrosine kinase inhibitors comprising pyridine and pyrimidine derivatives
|
|
WO2009096198A1
(ja)
*
|
2008-02-01 |
2009-08-06 |
Pharma Ip Limited Liability Intermediary Corporations |
新規ビアリール誘導体
|
|
JP2011511005A
(ja)
|
2008-02-04 |
2011-04-07 |
オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド |
２−アミノピリジン系キナーゼ阻害薬
|
|
AR070317A1
(es)
*
|
2008-02-06 |
2010-03-31 |
Osi Pharm Inc |
Furo (3,2-c) piridina y tieno (3,2-c) piridinas
|
|
US20100311972A1
(en)
*
|
2008-02-18 |
2010-12-09 |
Mitsuo Nagai |
Method for producing phenoxypyridine derivative
|
|
US20110092452A1
(en)
*
|
2008-03-05 |
2011-04-21 |
The Regents Of The University Of Michigan |
Compositions and methods for diagnosing and treating pancreatic cancer
|
|
US8268834B2
(en)
*
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
|
FR2928922B1
(fr)
|
2008-03-21 |
2010-04-23 |
Sanofi Aventis |
Derives de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines polysubstitues, leur preparation et leur application en therapeutique
|
|
FR2928924B1
(fr)
|
2008-03-21 |
2010-04-23 |
Sanofi Aventis |
Derives polysubstitues de 6-heteroaryle-imidazo°1,2-a! pyridines, leur preparation et leur application en therapeutique
|
|
FR2928923B1
(fr)
|
2008-03-21 |
2010-04-23 |
Sanofi Aventis |
Derives polysubstitues de 2-heteroaryl-6-phenyl-imidazo °1,2-a!pyridines, leur preparation et leur application en therapeutiques
|
|
WO2009151800A1
(en)
*
|
2008-05-07 |
2009-12-17 |
Merck & Co., Inc. |
Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
|
|
NZ602791A
(en)
|
2008-05-21 |
2014-04-30 |
Incyte Corp |
Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
|
|
ES2551899T3
(es)
*
|
2008-06-19 |
2015-11-24 |
Xcovery Holding Company Llc |
Compuestos de piridazina carboxamida sustituidos como compuestos inhibidores de cinasas
|
|
WO2010025414A2
(en)
*
|
2008-08-29 |
2010-03-04 |
Genentech, Inc. |
Diagnostics and treatments for vegf-independent tumors
|
|
WO2010046780A2
(en)
*
|
2008-10-22 |
2010-04-29 |
Institut Pasteur Korea |
Anti viral compounds
|
|
AT507187B1
(de)
|
2008-10-23 |
2010-03-15 |
Helmut Dr Buchberger |
Inhalator
|
|
US8592448B2
(en)
*
|
2008-11-20 |
2013-11-26 |
OSI Pharmaceuticals, LLC |
Substituted pyrrolo[2,3-b]-pyridines and -pyrazines
|
|
US8367679B2
(en)
*
|
2008-12-09 |
2013-02-05 |
Merck Sharp & Dohme Corp. |
Biaryl carboxamides
|
|
EP2376485B1
(en)
|
2008-12-19 |
2017-12-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazine derivatives useful as inhibitors of atr kinase
|
|
BRPI0922435A2
(pt)
|
2008-12-19 |
2018-09-11 |
Sirtris Pharmaceuticals Inc |
"composto de tiazolopiridina moduladores de sirtuina, composição farmacêutica compreendendo o mesmo e seu uso."
|
|
JP2012102018A
(ja)
*
|
2009-03-03 |
2012-05-31 |
Astellas Pharma Inc |
アミド化合物
|
|
TW201100441A
(en)
|
2009-06-01 |
2011-01-01 |
Osi Pharm Inc |
Amino pyrimidine anticancer compounds
|
|
DE102009056886A1
(de)
|
2009-12-03 |
2011-06-09 |
Bayer Schering Pharma Aktiengesellschaft |
cMet-Inhibitoren zur Behandlung der Endometriose
|
|
AU2011269788B2
(en)
|
2010-02-03 |
2015-12-10 |
Incyte Holdings Corporation |
Imidazo[1,2-b][1,2,4]triazines as c-Met inhibitors
|
|
US8916593B2
(en)
|
2010-05-04 |
2014-12-23 |
Pfizer Inc. |
Alkoxy-substituted 2-aminopyridines as ALK inhibitors
|
|
KR20130066633A
(ko)
|
2010-05-12 |
2013-06-20 |
버텍스 파마슈티칼스 인코포레이티드 |
Ａｔｒ 키나제의 억제제로서 유용한 화합물
|
|
EP2569286B1
(en)
*
|
2010-05-12 |
2014-08-20 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
|
JP2013526540A
(ja)
|
2010-05-12 |
2013-06-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ａｔｒキナーゼ阻害剤として有用な化合物
|
|
WO2011143646A1
(en)
|
2010-05-14 |
2011-11-17 |
OSI Pharmaceuticals, LLC |
Fused bicyclic kinase inhibitors
|
|
AR081039A1
(es)
|
2010-05-14 |
2012-05-30 |
Osi Pharmaceuticals Llc |
Inhibidores biciclicos fusionados de quinasa
|
|
US9526648B2
(en)
|
2010-06-13 |
2016-12-27 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
US8628554B2
(en)
|
2010-06-13 |
2014-01-14 |
Virender K. Sharma |
Intragastric device for treating obesity
|
|
US10420665B2
(en)
|
2010-06-13 |
2019-09-24 |
W. L. Gore & Associates, Inc. |
Intragastric device for treating obesity
|
|
US10010439B2
(en)
|
2010-06-13 |
2018-07-03 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
MX2012014776A
(es)
|
2010-06-25 |
2013-01-29 |
Eisai R&D Man Co Ltd |
Agente antitumoral que emplea compuestos con efecto inhibidor de cinasas combinados.
|
|
WO2012007836A1
(en)
|
2010-07-16 |
2012-01-19 |
Purdue Pharma .Lp. |
Pyridine compounds as sodium channel blockers
|
|
WO2012042421A1
(en)
|
2010-09-29 |
2012-04-05 |
Pfizer Inc. |
Method of treating abnormal cell growth
|
|
BR112013008523B1
(pt)
|
2010-10-08 |
2021-12-07 |
Xcovery Holdings, Inc |
Compostos de piridazina carboxamida substituídos e usos dos mesmos para tratar câncer, uma doença de proliferação, uma doença neurológica, uma doença psiquiátrica, obesidade, diabetes ou doença cardiovascular
|
|
PL2646448T3
(pl)
|
2010-11-29 |
2017-12-29 |
OSI Pharmaceuticals, LLC |
Makrocykliczne inhibitory kinazy
|
|
GB201021103D0
(en)
|
2010-12-13 |
2011-01-26 |
Univ Leuven Kath |
New compounds for the treatment of neurodegenerative diseases
|
|
HUE026804T2
(en)
|
2011-02-11 |
2016-07-28 |
Batmark Ltd |
Inhaler component
|
|
CN103826641B
(zh)
*
|
2011-02-24 |
2018-09-07 |
江苏豪森药业集团有限公司 |
作为蛋白激酶抑制剂的含磷化合物
|
|
US9145390B2
(en)
|
2011-03-03 |
2015-09-29 |
Concert Pharmaceuticals, Inc. |
Derivatives of pyrazole-substituted amino-heteroaryl compounds
|
|
JO3438B1
(ar)
*
|
2011-04-13 |
2019-10-20 |
Epizyme Inc |
مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
|
|
US20140113824A1
(en)
|
2011-05-10 |
2014-04-24 |
Bayer Intellectual Property Gmbh |
Bicyclic (thio)carbonylamidines
|
|
EP2710003A1
(en)
|
2011-05-16 |
2014-03-26 |
OSI Pharmaceuticals, LLC |
Fused bicyclic kinase inhibitors
|
|
EP2723746A1
(en)
|
2011-06-22 |
2014-04-30 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
|
CA2842841C
(en)
*
|
2011-07-27 |
2016-04-19 |
Nanjing Allgen Pharma Co. Ltd. |
Spirocyclic molecules as protein kinase inhibitors
|
|
CN103841972A
(zh)
|
2011-08-02 |
2014-06-04 |
辉瑞公司 |
用于癌症的治疗的克里唑蒂尼
|
|
KR102056586B1
(ko)
|
2011-09-30 |
2019-12-18 |
버텍스 파마슈티칼스 인코포레이티드 |
Ａｔｒ 억제제를 이용한 췌장암 및 비소세포 폐암의 치료
|
|
BR112014007721B1
(pt)
|
2011-09-30 |
2022-11-01 |
Vertex Pharmaceuticals Incorporated |
Processos para preparar compostos úteis como inibidores de atr quinase
|
|
ES2621220T3
(es)
|
2012-03-06 |
2017-07-03 |
Pfizer Inc. |
Derivados macrocíclicos para el tratamiento de enfermedades proliferativas
|
|
AU2013203824A1
(en)
|
2012-03-16 |
2013-10-03 |
Purdue Pharma L.P. |
Substituted pyridines and pryimidines as sodium channel blockers
|
|
JP2015515478A
(ja)
|
2012-04-05 |
2015-05-28 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
Ａｔｒキナーゼの阻害剤として有用な化合物及びそれらの併用療法
|
|
WO2013152252A1
(en)
|
2012-04-06 |
2013-10-10 |
OSI Pharmaceuticals, LLC |
Combination anti-cancer therapy
|
|
EP2836216B1
(en)
*
|
2012-04-13 |
2022-06-08 |
Epizyme, Inc. |
Combination therapy for treating cancer
|
|
CN103387535B
(zh)
*
|
2012-05-10 |
2016-06-01 |
广东东阳光药业有限公司 |
取代的炔基吡啶化合物及其使用方法和用途
|
|
WO2013177092A1
(en)
*
|
2012-05-23 |
2013-11-28 |
Sunshine Lake Pharma Co., Ltd. |
Substituted alkynyl pyridine compounds and methods of use
|
|
GB201211310D0
(en)
|
2012-06-26 |
2012-08-08 |
Chroma Therapeutics Ltd |
CSF-1R kinase inhibitors
|
|
JP6280546B2
(ja)
|
2012-06-26 |
2018-02-14 |
デル マー ファーマシューティカルズ |
ジアンヒドロガラクチトール、ジアセチルジアンヒドロガラクチトール、ジブロモズルシトール、又はこれらの類似体若しくは誘導体を用いた、遺伝子多型又はａｈｉ１の調節不全若しくは変異を有する患者におけるチロシンキナーゼインヒビター抵抗性悪性腫瘍を処置するための方法
|
|
WO2014046730A1
(en)
|
2012-09-24 |
2014-03-27 |
Ventana Medical Systems, Inc. |
Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (alk) as a marker
|
|
US8999632B2
(en)
|
2012-10-04 |
2015-04-07 |
Vertex Pharmaceuticals Incorporated |
Method for measuring ATR inhibition mediated increases in DNA damage
|
|
US20150299170A1
(en)
*
|
2012-11-21 |
2015-10-22 |
Concert Pharmaceuticals, Inc. |
Fluoro-derivatives of pyrazole-substituted amino-heteroaryl compounds
|
|
BR112015012454B1
(pt)
|
2012-12-07 |
2022-07-05 |
Vertex Pharmaceuticals Incorporated |
Compostos inibidores de atr quinase, seu uso e composição farmacêutica compreendendo os mesmos
|
|
US9714252B2
(en)
|
2012-12-20 |
2017-07-25 |
Purdue Pharma L.P. |
Cyclic sulfonamides as sodium channel blockers
|
|
US9334239B2
(en)
|
2012-12-21 |
2016-05-10 |
Eisai R&D Management Co., Ltd. |
Amorphous form of quinoline derivative, and method for producing same
|
|
CA2899968C
(en)
*
|
2013-02-02 |
2016-12-20 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Substituted 2-aminopyridine protein kinase inhibitor
|
|
WO2014143240A1
(en)
|
2013-03-15 |
2014-09-18 |
Vertex Pharmaceuticals Incorporated |
Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
|
|
EP2983674A4
(en)
|
2013-04-08 |
2017-05-10 |
Dennis M. Brown |
Therapeutic benefit of suboptimally administered chemical compounds
|
|
US10517861B2
(en)
|
2013-05-14 |
2019-12-31 |
Eisai R&D Management Co., Ltd. |
Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
|
|
WO2015034729A1
(en)
*
|
2013-09-05 |
2015-03-12 |
Calitor Sciences, Llc |
Substituted pyridine compounds and methods of use
|
|
US20160214961A1
(en)
*
|
2013-09-10 |
2016-07-28 |
Shilpa Medicare Limited |
Novel salts of crizotinib and their preparation
|
|
RU2550346C2
(ru)
|
2013-09-26 |
2015-05-10 |
Общество с ограниченной ответственностью "Отечественные Фармацевтические Технологии" ООО"ФармТех" |
Новые химические соединения (варианты) и их применение для лечения онкологических заболеваний
|
|
AU2013402175B2
(en)
|
2013-09-30 |
2017-09-07 |
Handok Inc. |
Novel triazolopyrazine derivative and use thereof
|
|
WO2015069922A2
(en)
|
2013-11-06 |
2015-05-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Alk antibodies, conjugates, and chimeric antigen receptors, and their use
|
|
ES2768678T3
(es)
|
2013-12-06 |
2020-06-23 |
Vertex Pharma |
Compuesto de 2-amino-6-fluoro-N-[5-fluoro-piridin-3-il]pirazolo[1,5-a]pirimidin-3-carboxamida útil como inhibidor de la ATR quinasa, su preparación, diferentes formas sólidas y derivados radiomarcados de las mismas
|
|
KR20160100329A
(ko)
|
2013-12-20 |
2016-08-23 |
3-브이 바이오사이언시스, 인코포레이티드 |
지질 합성의 헤테로사이클릭 조절물질 및 이들의 조합물
|
|
CN103755627B
(zh)
*
|
2014-01-09 |
2016-02-17 |
定陶县友帮化工有限公司 |
2-氨基-3-羟基-5-氯吡啶的合成方法
|
|
TWI672141B
(zh)
|
2014-02-20 |
2019-09-21 |
美商醫科泰生技 |
投予ｒｏｓ１突變癌細胞之分子
|
|
EP3122900A1
(en)
|
2014-03-24 |
2017-02-01 |
F. Hoffmann-La Roche AG |
Cancer treatment with c-met antagonists and correlation of the latter with hgf expression
|
|
US10730866B2
(en)
|
2014-04-07 |
2020-08-04 |
Purdue Pharma L.P. |
Indole derivatives and use thereof
|
|
US10052332B2
(en)
|
2014-04-29 |
2018-08-21 |
Emory University |
Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto
|
|
WO2015172747A1
(en)
*
|
2014-05-16 |
2015-11-19 |
Zhaoyin Wang |
Spirocyclic molecules as mth1 inhibitors
|
|
ES2777608T3
(es)
|
2014-06-05 |
2020-08-05 |
Vertex Pharma |
Derivados radiomarcados de un compuesto de 2-amino-6-fluoro-N-[5-fluoro-piridin-3-il]-pirazolo[1,5-a]pirimidin-3-carboxamida útiles como inhibidores de ATR cinasa, la preparación de dicho compuesto y diferentes formas sólidas del mismo
|
|
KR20170016498A
(ko)
|
2014-06-17 |
2017-02-13 |
버텍스 파마슈티칼스 인코포레이티드 |
Chk1 및 atr 저해제의 병용물을 사용하는 암의 치료 방법
|
|
CN106661064B
(zh)
*
|
2014-08-07 |
2019-10-15 |
江苏豪森药业集团有限公司 |
一种抗癌化合物的新晶型及其制备方法和用途
|
|
JP6633618B2
(ja)
|
2014-08-21 |
2020-01-22 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
強力なｒｏｃｋ阻害剤としてのタイドバックのベンズアミド誘導体
|
|
CN106660964B
(zh)
|
2014-08-28 |
2021-09-03 |
卫材R&D管理有限公司 |
高纯度喹啉衍生物及其生产方法
|
|
BR112017007708B8
(pt)
|
2014-10-13 |
2023-10-24 |
Atrin Pharmaceuticals LLC |
Composto macrocíclico e composição farmacêutica
|
|
GB2535427A
(en)
|
2014-11-07 |
2016-08-24 |
Nicoventures Holdings Ltd |
Solution
|
|
UY36391A
(es)
*
|
2014-11-05 |
2016-06-01 |
Flexus Biosciences Inc |
Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen
|
|
JP6902466B2
(ja)
*
|
2014-11-07 |
2021-07-14 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
ミオカルディン関連転写因子および血清応答因子（ｍｒｔｆ／ｓｒｆ）媒介性遺伝子転写の阻害剤ならびにその使用方法
|
|
CN107207471B
(zh)
|
2014-12-02 |
2020-06-26 |
伊尼塔公司 |
用于治疗神经母细胞瘤的组合
|
|
US20180000771A1
(en)
|
2015-01-13 |
2018-01-04 |
Kyoto University |
Agent for preventing and/or treating amyotrophic lateral sclerosis
|
|
PL3263106T3
(pl)
|
2015-02-25 |
2024-04-02 |
Eisai R&D Management Co., Ltd. |
Sposób tłumienia goryczy pochodnej chinoliny
|
|
MA41598A
(fr)
*
|
2015-02-25 |
2018-01-02 |
Constellation Pharmaceuticals Inc |
Composés thérapeutiques de pyridazine et leurs utilisations
|
|
KR102662228B1
(ko)
|
2015-03-04 |
2024-05-02 |
머크 샤프 앤드 돔 코포레이션 |
암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
|
|
US10464896B2
(en)
|
2015-06-11 |
2019-11-05 |
Basilea Pharmaceutica International AG |
Efflux-pump inhibitors and therapeutic uses thereof
|
|
ES2886107T3
(es)
|
2015-06-16 |
2021-12-16 |
Prism Biolab Co Ltd |
Antineoplásico
|
|
US10405627B2
(en)
*
|
2015-07-14 |
2019-09-10 |
Michael Charles Boland, III |
Luggage with fold out table
|
|
AU2016309356B2
(en)
|
2015-08-20 |
2021-06-24 |
Eisai R&D Management Co., Ltd. |
Tumor therapeutic agent
|
|
KR102678021B1
(ko)
|
2015-09-30 |
2024-06-26 |
버텍스 파마슈티칼스 인코포레이티드 |
Dna 손상제와 병용되는, atr 저해제를 포함하는 암 치료용 약제학적 조성물
|
|
GB2542838B
(en)
|
2015-10-01 |
2022-01-12 |
Nicoventures Trading Ltd |
Aerosol provision system
|
|
WO2017106492A1
(en)
|
2015-12-18 |
2017-06-22 |
Ignyta, Inc. |
Combinations for the treatment of cancer
|
|
WO2017161004A1
(en)
|
2016-03-15 |
2017-09-21 |
University Of South Florida |
PKCδ INHIBITOR FORMULATIONS AND USES THEREOF CROSS-REFERENCE TO RELATED APPLICATIONS
|
|
WO2017180723A1
(en)
|
2016-04-12 |
2017-10-19 |
Atrin Pharmaceuticals LLC |
Ataxia telengiectasia and rad3-related (atr) inhibitors and methods of their use
|
|
US10779980B2
(en)
|
2016-04-27 |
2020-09-22 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
EP3463355B1
(en)
*
|
2016-05-26 |
2024-08-28 |
Sonic Master Limited |
Modulators of dux4 for regulation of muscle function
|
|
TWI646094B
(zh)
|
2016-06-01 |
2019-01-01 |
大陸商貝達藥業股份有限公司 |
Crystal form of inhibitory protein kinase active compound and application thereof
|
|
JP7120549B2
(ja)
|
2016-12-15 |
2022-08-17 |
小野薬品工業株式会社 |
Ｔｒｅｋ（ｔｗｉｋ関連ｋチャネル）チャネルのアクチベータ
|
|
CN106866627B
(zh)
*
|
2017-01-24 |
2021-09-14 |
南方医科大学 |
3-(1-(氨基吡啶氧基)乙基)苯甲酰胺衍生物及其合成方法和应用
|
|
MX380144B
(es)
|
2017-02-08 |
2025-03-12 |
Eisai R&D Man Co Ltd |
Composicion farmaceutica de tratamiento de tumores.
|
|
CA3061888A1
(en)
|
2017-05-16 |
2018-11-22 |
Eisai R&D Management Co., Ltd. |
Treatment of hepatocellular carcinoma
|
|
BR112020000962A2
(pt)
|
2017-07-18 |
2020-07-14 |
Nuvation Bio Inc. |
compostos de 1,8-naftiridinona e usos dos mesmos
|
|
MX2020000690A
(es)
|
2017-07-18 |
2020-07-29 |
Nuvation Bio Inc |
Compuestos heterociclicos como antagonistas de adenosina.
|
|
EP3654952A1
(en)
|
2017-07-19 |
2020-05-27 |
Ignyta, Inc. |
Pharmaceutical compositions comprising entrectinib
|
|
CN111225662B
(zh)
|
2017-10-17 |
2022-11-22 |
伊尼塔公司 |
药物组合物和剂型
|
|
CN107794282B
(zh)
*
|
2017-11-20 |
2020-12-25 |
浙江工业大学 |
一种克唑替尼手性中间体的制备方法及菌株
|
|
WO2019154665A1
(en)
*
|
2018-02-07 |
2019-08-15 |
Basf Se |
New pyridine carboxamides
|
|
CN111601790B
(zh)
*
|
2018-03-15 |
2023-03-31 |
福建海西新药创制股份有限公司 |
作为蛋白激酶抑制剂的杂芳基化合物
|
|
CN110372664A
(zh)
*
|
2018-04-13 |
2019-10-25 |
华东理工大学 |
选择性jak2抑制剂及其应用
|
|
WO2019206049A1
(en)
*
|
2018-04-25 |
2019-10-31 |
Zhuhai Yufan Biotechnologies Co., Ltd |
Hpk1 inhibitors, preparation method and application thereof
|
|
CN110396087A
(zh)
*
|
2018-04-25 |
2019-11-01 |
珠海宇繁生物科技有限责任公司 |
Hpk1激酶抑制剂、制备方法及其应用
|
|
CN108947895B
(zh)
*
|
2018-08-22 |
2021-09-24 |
肇庆中彩机电技术研发有限公司 |
一种抗癌活性的化合物
|
|
AU2020207952A1
(en)
*
|
2019-01-18 |
2021-08-26 |
Nuvation Bio Inc. |
Heterocyclic compounds as adenosine antagonists
|
|
EP3911323A4
(en)
|
2019-01-18 |
2022-11-16 |
Nuvation Bio Inc. |
HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS
|
|
CA3126931A1
(en)
|
2019-01-18 |
2020-07-23 |
Nuvation Bio Inc. |
1,8-naphthyridinone compounds and uses thereof
|
|
EP4628487A3
(en)
|
2019-03-20 |
2025-12-24 |
Emory University |
Prostaglandin receptor ep2 antagonists, derivatives, and uses related thereto
|
|
WO2020228747A1
(en)
|
2019-05-14 |
2020-11-19 |
Teligene Ltd |
Substituted macrocycles useful as kinase inhibitors
|
|
KR102426921B1
(ko)
|
2019-09-24 |
2022-07-29 |
주식회사 이노보테라퓨틱스 |
헤테로아릴아미도피리딘올 유도체 및 이를 유효성분으로 포함하는 자가면역질환의 예방 또는 치료용 약학적 조성물
|
|
CN112552293A
(zh)
*
|
2019-09-25 |
2021-03-26 |
珠海宇繁生物科技有限责任公司 |
一种protac小分子化合物及其应用
|
|
KR102344185B1
(ko)
*
|
2020-02-26 |
2021-12-27 |
계명대학교 산학협력단 |
신규한 Pim 키나아제 억제제 및 이의 용도
|
|
CN113493437B
(zh)
*
|
2020-04-03 |
2022-07-26 |
中国药科大学 |
含苯并咪唑结构的化合物及其制备方法和用途
|
|
WO2021196655A1
(zh)
*
|
2020-04-03 |
2021-10-07 |
中国药科大学 |
含苯并咪唑结构的化合物及其制备方法与用途
|
|
WO2023086671A1
(en)
*
|
2021-11-15 |
2023-05-19 |
The Broad Institute, Inc. |
Compounds, compositions, and methods for inducing antimicrobial intracellular activity and for preventing and treating microbial infections
|
|
TW202412771A
(zh)
|
2022-07-04 |
2024-04-01 |
日商中外製藥股份有限公司 |
併用醫藥
|
|
KR20250055574A
(ko)
|
2022-08-30 |
2025-04-24 |
추가이 세이야쿠 가부시키가이샤 |
병용 의약
|